TR200000890T2 - Topik ilacın üretilmesi için -amino levülozik asidin kullanılması - Google Patents

Topik ilacın üretilmesi için -amino levülozik asidin kullanılması

Info

Publication number
TR200000890T2
TR200000890T2 TR2000/00890T TR200000890T TR200000890T2 TR 200000890 T2 TR200000890 T2 TR 200000890T2 TR 2000/00890 T TR2000/00890 T TR 2000/00890T TR 200000890 T TR200000890 T TR 200000890T TR 200000890 T2 TR200000890 T2 TR 200000890T2
Authority
TR
Turkey
Prior art keywords
acid
levulosic
amino
topical drug
medicament
Prior art date
Application number
TR2000/00890T
Other languages
English (en)
Inventor
Heisig Wolfgang
Bach Ferdinand
Original Assignee
Medac Gesellschaft Fur Klinische Spezialpraeparate Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medac Gesellschaft Fur Klinische Spezialpraeparate Mbh filed Critical Medac Gesellschaft Fur Klinische Spezialpraeparate Mbh
Publication of TR200000890T2 publication Critical patent/TR200000890T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Kaviteli organlarin içindeki tümörlerin entegral diyagnozu ve/veya terapisi için -amino levülinik asit esasina dayanan.topik olarak uygulanabilen bir ilaç teklif edilmekte olup, bu ilaç sulu bir çözeltinin içinde, aktif maddenin yanisira,fizyolojik açidan tolere edilebilen bir asidi ve regülatör ve 4,8, ila 5,2 olan bir pH degerine sahiptir.Ilaç stabil olup,bilhassa iyi tolere edilebilir.
TR2000/00890T 1997-10-02 1998-09-21 Topik ilacın üretilmesi için -amino levülozik asidin kullanılması TR200000890T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19744811A DE19744811C2 (de) 1997-10-02 1997-10-02 Verwendung von delta-Aminolävulinsäure zur Herstellung eines topischen Arzneimittels zur integralen Diagnose und/oder Therapie von Tumoren in Hohlorganen

Publications (1)

Publication Number Publication Date
TR200000890T2 true TR200000890T2 (tr) 2000-08-21

Family

ID=7845169

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00890T TR200000890T2 (tr) 1997-10-02 1998-09-21 Topik ilacın üretilmesi için -amino levülozik asidin kullanılması

Country Status (13)

Country Link
EP (1) EP1019037B9 (tr)
JP (1) JP2001518498A (tr)
AT (1) ATE203903T1 (tr)
AU (1) AU729973B2 (tr)
DE (2) DE19744811C2 (tr)
DK (1) DK1019037T3 (tr)
ES (1) ES2159967T3 (tr)
GR (1) GR3036481T3 (tr)
NZ (1) NZ503802A (tr)
PT (1) PT1019037E (tr)
TR (1) TR200000890T2 (tr)
WO (1) WO1999017764A1 (tr)
ZA (1) ZA988820B (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040009212A1 (en) * 2002-01-30 2004-01-15 Pharma Power Biotec Co. Ltd. Mucoadhesive thermoresponsive medicament-carrier composition
JP5081121B2 (ja) * 2008-10-17 2012-11-21 株式会社ミルボン 育毛剤組成物
JPWO2018043240A1 (ja) * 2016-09-02 2019-06-24 Ｓｂｉファーマ株式会社 ５−アミノレブリン酸類を含む水性製剤
RU2630124C1 (ru) * 2016-10-06 2017-09-05 федеральное государственное бюджетное образовательное учреждение высшего образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ интраоперационной диагностики и лечения злокачественных новообразований органов брюшной полости
CN115671059B (zh) * 2022-11-17 2024-06-11 兆科药业（合肥）有限公司 一种盐酸氨酮戊酸冻干制剂及制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
US5079262A (en) * 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
FR2690340B1 (fr) * 1992-04-24 1995-02-24 Scr Newmed Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
DE4228106A1 (de) * 1992-08-24 1994-03-03 Medac Klinische Spezialpraep Verwendung von £-Aminolävulinsäure zur Herstellung eines topischen Arzneimittels zur integralen Diagnose und/oder Therapie von Tumoren in Hohlorganen
DE4320871C2 (de) * 1993-06-24 1995-05-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure
PH31226A (en) * 1993-08-19 1998-05-12 Blazley Design Pty Ltd Explosion resistant building structures.
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
MX9504023A (es) * 1994-09-20 1997-05-31 Johnson & Johnson Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion.

Also Published As

Publication number Publication date
AU1024299A (en) 1999-04-27
PT1019037E (pt) 2001-11-30
EP1019037B1 (de) 2001-08-08
ZA988820B (en) 1999-04-06
JP2001518498A (ja) 2001-10-16
NZ503802A (en) 2000-12-22
DE19744811A1 (de) 1999-04-15
DK1019037T3 (da) 2001-10-01
AU729973B2 (en) 2001-02-15
GR3036481T3 (en) 2001-11-30
EP1019037A1 (de) 2000-07-19
EP1019037B9 (de) 2002-04-17
DE59801192D1 (de) 2001-09-13
WO1999017764A1 (de) 1999-04-15
DE19744811C2 (de) 1999-11-18
ES2159967T3 (es) 2001-10-16
ATE203903T1 (de) 2001-08-15

Similar Documents

Publication Publication Date Title
ATE290401T1 (de) Topisch anwendbare mittel gegen nagelpilzerkrankungen
GB0105772D0 (en) Use
ZA200305412B (en) 4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical.
SE0001899D0 (sv) New compounds
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
MY130441A (en) Solutions containing epinastin
PL357132A1 (en) Stable, nasally, orally or sublingually applicable pharmaceutical preparation
CA2396186A1 (en) Agents for the treatment of skin disorders
HUP9801924A2 (hu) Nátrium/hidrogén-csere inhibitorokat és szív- és keringési zavarok kezelésére alkalmas hatóanyagokat tartalmazó gyógyszerkészítmény
NZ507203A (en) Use of dexmedetomidine for ICU sedation
TW337997B (en) Pharmaceutical preparation containing plasminogen activators
EA200200151A1 (ru) Сухая порошкообразная композиция
TR200000890T2 (tr) Topik ilacın üretilmesi için -amino levülozik asidin kullanılması
ES2052000T3 (es) Procedimiento para preparar composiciones farmaceuticas que contienen pentamidina.
EP1108429A3 (en) An improved amino acid composition for providing an amino acid supplement or protein substitute, particularly for the treatment and/or management of certain diseases
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
MXPA01007210A (es) Agente para el tratamiento de enfermedad de parkinson que comprende un agente que mejora la funcion del astrocito como ingrediente activo.
IT1306147B1 (it) Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali
ATE249820T1 (de) Zubereitung für warzen
HUP9802005A2 (hu) Nátrium/hidrogén-csere inhibitorok alkalmazása különböző anyagok által a szívre gyakorolt nem kívánt hatások csökkentésére alkalmas gyógyszerkészítmények előállítására
ATE258046T1 (de) Pharmazeutische, metamizol enthaltende brauseformulierung
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
DE68901852D1 (de) Primycin-loesungen.
RS49796B (sr) UPOTREBA SOLI 3α, 7α-DIHIDROKSI-12-KETO-5β-HOLANSKE KISELINE KAO AKTIVNE SUPSTANCE ZA IZRADU LEKOVA ZA LEČENJE DIJABETESA